cefazolin has been researched along with Peripheral Vascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| AbuRahma, AF; Campbell, JR; Emmett, M; Hass, SM; Modak, A; Mousa, AY; Nanjundappa, A; Srivastiva, M; Stone, PA | 1 |
| Bader, MS; Hawboldt, J; Twells, L | 1 |
| Hoaglund, PA; Shoultz, DA; Tice, AD | 1 |
| Goldman, L | 1 |
| Jones, MJ; Kerins, CA; Peek, TE; Ross, CB; Wheeler, WG | 1 |
2 trial(s) available for cefazolin and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Prospective randomized double-blinded trial comparing 2 anti-MRSA agents with supplemental coverage of cefazolin before lower extremity revascularization.
Topics: Adult; Aged; Antibiotic Prophylaxis; Cefazolin; Chi-Square Distribution; Daptomycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lower Extremity; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Patient Safety; Peripheral Vascular Diseases; Preoperative Care; Prospective Studies; Radiography; Risk Assessment; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin; Vascular Surgical Procedures | 2015 |
Ceftriaxone versus cefazolin in peripheral arterial operations: a randomized, prospective trial.
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Arteries; Cefazolin; Ceftriaxone; Cephalosporins; Female; Humans; Incidence; Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Reoperation; Risk Factors; Surgical Wound Infection | 1997 |
3 other study(ies) available for cefazolin and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefazolin; Cellulitis; Chi-Square Distribution; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Probenecid; Retrospective Studies; Risk Factors; Treatment Failure; Veins | 2011 |
Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amputation, Surgical; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Child; Diabetes Complications; Female; Humans; Infusions, Intravenous; Male; Medical Records; Middle Aged; Osteomyelitis; Outcome Assessment, Health Care; Penicillins; Peripheral Vascular Diseases; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Vancomycin; Washington | 2003 |
Overlapping publications.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Diabetes Mellitus; Duplicate Publications as Topic; Humans; Osteomyelitis; Penicillins; Peripheral Vascular Diseases; Staphylococcal Infections | 2003 |